Pharmacotherapy Before and After Revascularization: Anticoagulation, Antiplatelet Agents, and Statins

Seminars in Vascular Surgery

Volumn 20, Issue 1, 2007, Pages 10-14

  Dagher, Nabil N ^a   Modrall, J Gregory ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PLACEBO; SIMVASTATIN; TICLOPIDINE; WARFARIN;

ANTICOAGULATION; ARTERY DISEASE; ARTICLE; BYPASS SURGERY; CLAUDICATION; CLINICAL TRIAL; DRUG DOSE COMPARISON; DRUG INDICATION; DRUG USE; ENDOVASCULAR SURGERY; GRAFT FAILURE; GRAFT PATENCY; HUMAN; NEUTROPENIA; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL TIME; SYMPTOM; THROMBOCYTOPENIA; THROMBOSIS; TREATMENT OUTCOME; VEIN GRAFT;

ANTICOAGULANTS; COMBINED MODALITY THERAPY; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INTERMITTENT CLAUDICATION; PATIENT SELECTION; PERIPHERAL VASCULAR DISEASES; PLATELET AGGREGATION INHIBITORS; PRACTICE GUIDELINES; TREATMENT OUTCOME; VASCULAR SURGICAL PROCEDURES;

EID: 33947391635     PISSN: 08957967     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semvascsurg.2007.02.006     Document Type: Article

References (39)

1. Cosmi B., Conti E., and Coccheri S. Anticoagulants (heparin, low molecular weight heparin and oral anticoagulants) for intermittent claudication. Cochrane Database Syst Rev 2 (2001) CD001999
2. Dorffler-Melly J., Buller H.R., Koopman M.M.W., and Prins M.H. Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery. Cochrane Database Syst Rev 2 (2003) CD000536
3. Collins T.C., Souchek J., and Beyth R.J. Benefits of antithrombotic therapy after infrainguinal bypass: a meta-analysis. Am J Med 117 (2004) 93-99
4. Kretschmer G., Herbst F., Prager M., et al. A decade of oral anticoagulant treatment to maintain autologous vein grafts for femoropopliteal atherosclerosis. Arch Surg 127 (1992) 1112-1115
5. Dutch Bypass Oral Anticoagulants or Aspirin Study Group. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch bypass oral anticoagulants or aspirin study): a randomised trial. Lancet 355 (2000) 346-351
6. Johnson W.C., and Williford W.O. Benefits, morbidity, and mortality associated with long-term administration of oral anticoagulant therapy to patients with peripheral arterial bypass procedures: a prospective randomized study. J Vasc Surg 35 (2002) 413-421
7. Sarac T.P., Huber T.S., Back M.R., et al. Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure. J Vasc Surg 28 (1988) 446-457
8. Schneider E., Mahler F., Do D.D., et al. Zur rezidivprophlaxe nach perkutanes transluminaler angioplastie (PTA): antikoagulation versus Ticlopidin. Vasa 16 (1987) 355-356
9. Pilger E., Lammer J., Bertuch H., et al. Yag laser with sapphire tip combined with balloon angioplasty in peripheral arterial occlusions: long-term results. Circulation 83 (1991) 141-147
10. Do D.D., and Mahler F. Low-dose aspirin combined with dipyridamole versus anticoagulants after femoropopliteal percutaneous transluminal angioplasty. Radiology 193 (1994) 567-571
11. Clagett G.P., Sobel M., Jackson M.R., et al. Antithrombotic therapy in peripheral arterial occlusive disease: the seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 126 (2004) 609S-626S
12. Dorffler-Melly J., Koopman M.M.W., Prins M.H., and Buller H.R. Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment. Cochrane Database Syst Rev 1 (2005) CD002071
13. WAVE Study Investigators. The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design and baseline characteristics of the WAVE trial including a meta-analysis of trials. Am Heart J 151 (2006) 1-9
14. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy: I. Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Br Med J 308 (1994) 1-106
15. Patrono C., Garcia-Rodriguez L.A., Landolfi R., and Baigent C. Low-dose aspirin for the prevention of atherothrombosis. N Engl J Med 353 (2005) 2373-2383
16. Hess H., Mietaschik A., and Deichsel G. Drug-induced inhibition of platelet function delays progression of peripheral occlusive arterial disease: a prospective double-blind arteriographically controlled trial. Lancet 1 (1985) 415-419
17. Goldhaber S.Z., Manson J.E., Stampfer M.J., et al. Low dose aspirin and subsequent peripheral arterial surgery in the Physicians' Health Study. Lancet 340 (1992) 143-145
18. Antiplatelet Trialists' Collaboration. Collaborative overview of randomized trials of antiplatelet therapy II: maintenance of vascular graft or arterial patency by antiplatelet therapy. Br Med J 308 (1994) 159-168
19. Dorffler-Melly J., Buller H.R., Koopman M.M.W., and Prins M.H. Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery. Cochrane Database Syst Rev 3 (2003) CD000535
20. Neilipovitz D.T., Bryson G.L., and Nichol G. The effect of perioperative aspirin therapy in peripheral vascular surgery: a decision analysis. Anesth Analg 93 (2001) 573-580
21. Watson H.R., Belcher G., and Horrocks M. Adjuvant medical therapy in peripheral bypass surgery. Br J Surg 86 (1999) 981-991
22. Tangelder M.J.D., Lawson J.A., Algra A., and Eikelboom B.C. Systematic review of randomized controlled trials of aspirin and oral anticoagulants in the prevention of graft occlusion and ischemic events after infrainguinal bypass. J Vasc Surg 30 (1999) 701-709
23. Hankey G.J., Norman P.E., and Eikelboom J.W. Medical treatment of peripheral arterial disease. JAMA 295 (2006) 547-553
24. Kam P.C., and Nethery C.M. The thienopyridine derivatives (platelet adenosine diphosphate receptor antagonists), pharmacology and clinical developments. Anesthesia 58 (2003) 28-35
25. CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischemic events (CAPRIE). Lancet 3481 (1996) 329-1339
26. Bhatt D.L., Fox K.A.A., Hacke W., et al. Clopidrogel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 354 (2006) 1706-1717
27. Becquemin J.P. Effect of ticlopidine on the long-term patency of saphenous-vein bypass grafts in the legs. N Engl J Med 337 (1997) 1726-1731
28. Lima J.A., Desai M.Y., Steen H., et al. Statin-induced cholesterol lowering and plaque regression after 6 months of magnetic resonance imaging-monitored therapy. Circulation 110 (2004) 2336-2341
29. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomized placebo-controlled trial. Lancet 360 (2002) 7-22
30. Sheperd J., Blauw G.J., Murphy M.N.B., et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomized controlled trial. Lancet 360 (2002) 1623-1630
31. Cholesterol Treatment Trialists' Collaborators. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
32. Pedersen T.R., Liekshus J., Pyorala K., et al. Effect of simvastatin on ischemic signs and symptoms in the Scandinavian Simvastatin Survival Study (4S). Am J Cardiol 81 (1998) 333-335
33. Mohler E.R., Hiatt W.R., and Creager M.A. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral vascular disease. Circulation 108 (2003) 1481-1486
34. Aronow W.S., Navak D., Woodworth S., et al. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol 92 (2003) 711-712
35. Mondillo S., Ballo P., Barbati R., et al. Effect on simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med 114 (2003) 359-364
36. McDermott M.M., Guralnik J.M., Greenland P., et al. Statin use and leg functioning in patients with and without lower-extremity peripheral disease. Circulation 107 (2003) 757-761
37. Abbruzzese T.A., Havens J., and Belkin M. Statin therapy is associated with improved patency of autogenous infrainguinal bypass grafts. J Vasc Surg 39 (2006) 1178-1185
38. Henke P., Blackburn S., Proctor M.C., et al. Patients undergoing infrainguinal bypass to treat atherosclerotic vascular disease are underprescribed cardioprotective medications: effect on graft patency, limb salvage, and mortality. J Vasc Surg 39 (2004) 357-365
39. Hirsch A.T., Haskal Z.J., Hertzer N.R., et al. ACC/AHA practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. Circulation 113 (2006) 1474-1547